OBJECTIVE: Magnetic resonance imaging (MRI) and ultrasonography (US) are commonly used in the pre-surgery determination of tumor size and the follow-up of breast cancer patients treated with neoadjuvant chemotherapy (NAC). The aim of this study was to compare the efficiency of preoperative MRI and US in tumor size evaluation of patients with breast cancer after NAC to guide clinicians on the appropriate treatment plan. MATERIALS AND METHODS: The study included a total of 75 patients who had undergone radiological follow-up, surgical treatment and pathological examination in our hospital between 2013 and 2016. Of these, 28 patients were followed-up with MRI and 47 with US. The dimension evaluations in pathology examination and on both MRI and US were based on the longest dimension of the tumor. RESULTS: There was no statistically significant difference between the tumor size measured pathologically and the size measured preoperatively on MRI (p=0.379). The tumor size measured on US before surgery was significantly smaller than the size measured in pathology (p=0.004). MRI did not overestimate by more than 10 mm in any patient, whereas US overestimated in 4 patients (8.6%). The correlation coefficient of MRI was higher than that of US (0.927 and 0.687, respectively). CONCLUSION: MRI is superior to US in preoperative tumor size evaluation of patients receiving NAC.
OBJECTIVE: Magnetic resonance imaging (MRI) and ultrasonography (US) are commonly used in the pre-surgery determination of tumor size and the follow-up of breast cancer patients treated with neoadjuvant chemotherapy (NAC). The aim of this study was to compare the efficiency of preoperative MRI and US in tumor size evaluation of patients with breast cancer after NAC to guide clinicians on the appropriate treatment plan. MATERIALS AND METHODS: The study included a total of 75 patients who had undergone radiological follow-up, surgical treatment and pathological examination in our hospital between 2013 and 2016. Of these, 28 patients were followed-up with MRI and 47 with US. The dimension evaluations in pathology examination and on both MRI and US were based on the longest dimension of the tumor. RESULTS: There was no statistically significant difference between the tumor size measured pathologically and the size measured preoperatively on MRI (p=0.379). The tumor size measured on US before surgery was significantly smaller than the size measured in pathology (p=0.004). MRI did not overestimate by more than 10 mm in any patient, whereas US overestimated in 4 patients (8.6%). The correlation coefficient of MRI was higher than that of US (0.927 and 0.687, respectively). CONCLUSION: MRI is superior to US in preoperative tumor size evaluation of patients receiving NAC.
Entities:
Keywords:
Breast cancer; magnetic resonance imaging; neoadjuvant chemotherapy; ultrasonography
Authors: M Rosselli Del Turco; A Ponti; U Bick; L Biganzoli; G Cserni; B Cutuli; T Decker; M Dietel; O Gentilini; T Kuehn; M P Mano; P Mantellini; L Marotti; P Poortmans; F Rank; H Roe; E Scaffidi; J A van der Hage; G Viale; C Wells; M Welnicka-Jaskiewicz; Y Wengstöm; L Cataliotti Journal: Eur J Cancer Date: 2010-07-31 Impact factor: 9.162
Authors: M Van Goethem; K Schelfout; E Kersschot; C Colpaert; I Verslegers; I Biltjes; W A Tjalma; A De Schepper; J Weyler; P M Parizel Journal: Eur J Radiol Date: 2007-01-12 Impact factor: 3.528
Authors: Anees B Chagpar; Lavinia P Middleton; Aysegul A Sahin; Peter Dempsey; Aman U Buzdar; Attiqa N Mirza; Fredrick C Ames; Gildy V Babiera; Barry W Feig; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Merrick I Ross; S Eva Singletary Journal: Ann Surg Date: 2006-02 Impact factor: 12.969
Authors: Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Dan Sudilovsky; Nola M Hylton Journal: AJR Am J Roentgenol Date: 2002-11 Impact factor: 3.959
Authors: Wendie A Berg; Lorena Gutierrez; Moriel S NessAiver; W Bradford Carter; Mythreyi Bhargavan; Rebecca S Lewis; Olga B Ioffe Journal: Radiology Date: 2004-10-14 Impact factor: 11.105
Authors: Constance D Lehman; Constantine Gatsonis; Christiane K Kuhl; R Edward Hendrick; Etta D Pisano; Lucy Hanna; Sue Peacock; Stanley F Smazal; Daniel D Maki; Thomas B Julian; Elizabeth R DePeri; David A Bluemke; Mitchell D Schnall Journal: N Engl J Med Date: 2007-03-28 Impact factor: 91.245
Authors: Davendra Segara; Ian E Krop; Judy E Garber; Eric Winer; Lyndsay Harris; Jennifer R Bellon; Robyn Birdwell; Susan Lester; Stuart Lipsitz; J Dirk Iglehart; Mehra Golshan Journal: J Surg Oncol Date: 2007-11-01 Impact factor: 3.454